Company intelligence / Profile preview
AFYX Therapeutics
Hørsholm / Copenhagen area, Denmarkafyxtx.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
AFYX Therapeutics is a clinical-stage biopharmaceutical company using its proprietary Rivelin mucoadhesive patch to deliver small‑molecule drugs directly to mucosal surfaces, with Phase 2b data showing that clobetasol Rivelin-CLO met primary and multiple secondary endpoints in oral lichen planus and Phase 2 data in vulvar lichen sclerosus, alongside ongoing work in other mucosal and head & neck indications.
- Therapeutic areas
- ImmunologyWomen's HealthNeurologyDermatologyGastroenterologyOncology
- Modalities
- Small moleculeDeviceNanoparticle (electrospun nano/microfiber)Hydrogel-based drug delivery therapy (mucoadhesive patch)Topical drug delivery system
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Lunatus (distribution and sales collaboration for Gefena misoprostol 25 μg tablet for induction of labor in Middle East markets)
Beyond the preview
Go deeper on AFYX Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AFYX Therapeutics.